引产前血清胎盘生长因子与可溶性fms样酪氨酸激酶-1对不良围产结局的预测
这项前瞻性观察研究纳入795例≥37周单胎引产孕妇,在引产前24小时内检测血清PlGF、sFlt-1及多普勒CPR。不良围产结局组血清PlGF中位数MoM较低(0.44 vs 0.60,P=0.003),但多因素回归显示PlGF与sFlt-1未提供显著额外贡献;母体危险因素联合CPR筛查的AUC为0.712,未显著优于单用母体危险因素的0.702(P=0.233)。
要点
- 引产前24小时内检测血清PlGF和sFlt-1,对不良围产结局预测未显示显著额外贡献。
- 不良围产结局组血清PlGF中位数MoM为0.44,低于无不良结局组的0.60(P=0.003)。
- 母体危险因素联合CPR筛查AUC为0.712,与单用母体危险因素的0.702无显著差异(P=0.233)。
核心结论
- 引产前24小时内测定的血清PlGF和sFlt-1,对母体危险因素预测不良围产结局未提供显著的额外贡献。
研究设计与样本
- 前瞻性观察研究,纳入795例≥37周单胎引产孕妇,引产前进行多普勒超声测量UA-PI、MCA-PI及CPR,并采血检测血清PlGF和sFlt-1。
主要发现
- 不良围产结局组血清PlGF中位数MoM为0.44(IQR 0.30-0.82),低于无不良结局组的0.60(IQR 0.36-1.07),P=0.003。
- 不良围产结局组与无不良结局组血清sFlt-1中位数MoM无显著差异(P=0.080)。
- 多因素回归分析显示,母体危险因素和CPR MoM对不良围产结局预测有显著贡献,而PlGF MoM和sFlt-1 MoM无显著贡献。
- 单用母体危险因素筛查的检出率为28.9%(假阳性率10%),加入CPR后检出率为33.8%(假阳性率10%),AUC分别为0.702(95%CI 0.654-0.750)与0.712(95%CI 0.664-0.760),P=0.233。
临床怎么用
- 原文结论认为引产前24小时内检测血清PlGF和sFlt-1未提供显著额外预测价值,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the additive value of serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1), measured within 24 h prior to induction of labor, to the performance of screening for adverse perinatal outcome provided by maternal risk factors and the cerebroplacental ratio (CPR). METHODS: This was a prospective observational study of 795 singleton pregnancies undergoing induction of labor at ≥ 37 weeks' gestation. Before induction of labor, Doppler ultrasound was used to measure the pulsatility index (PI) in the umbilical artery (UA) and fetal middle cerebral artery (MCA) and maternal blood was obtained for measurement of serum PlGF and sFlt-1. The measured UA-PI, MCA-PI and their ratio (CPR) were converted to multiples of the median (MoM) after adjustment for gestational age, and the measured PlGF and sFlt-1 were converted to MoM after adjustment for gestational age, maternal characteristics and the machine used for the assays. Univariable and multivariable logistic regression analysis was used to determine factors that provided a significant contribution in the prediction of adverse perinatal outcome, defined as the presence of any one of Cesarean section for non-reassuring fetal status in labor, umbilical arterial or venous cord blood pH ≤ 7 and ≤ 7.1, respectively, 5-min Apgar score < 7 or admission to the neonatal intensive care unit for ≥ 24 h. The detection rate (DR) and false-positive rate (FPR) in screening for adverse perinatal outcome were determined. RESULTS: In pregnancies with adverse perinatal outcome, compared to those without, median serum PlGF MoM was lower (0.44; interquartile range (IQR), 0.30-0.82 vs 0.60; IQR, 0.36-1.07; P = 0.003), but median sFlt-1 MoM was not significantly different (P = 0.080). Multivariable regression analysis demonstrated that, in the prediction of adverse perinatal outcome, there was significant contribution from maternal risk factors and CPR MoM but not PlGF MoM or sFlt-1 MoM. The performance of screening for adverse perinatal outcome achieved by maternal risk factors alone (DR of 28.9% at FPR of 10%) was not improved by the addition of CPR (DR of 33.8% at FPR of 10%) (area under the curve, 0.702; 95% CI, 0.654-0.750 vs 0.712; 95% CI, 0.664-0.760; P = 0.233). CONCLUSION: Serum PlGF and sFlt-1, measured within 24 h prior to induction of labor, do not provide a significant additional contribution to maternal risk factors in the prediction of adverse perinatal outcome. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Fiolna M, Machuca M, Karampitsakos T, et al. Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor. Ultrasound Obstet Gynecol. 2019. PMID: 31444934. doi:10.1002/uog.20853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。